▶ 調査レポート

卵巣がん治療薬の世界市場2021-2027

• 英文タイトル:Global Ovarian Cancer Therapeutics Market Size, Status and Forecast 2021-2027
• レポートコード:QYR2104Z4379
• 出版社/出版日:QYResearch / 2021年4月
• レポート形態:英文、PDF、94ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥514,800 (USD3,900)▷ お問い合わせ
  Multi User/Five User¥772,200 (USD5,850)▷ お問い合わせ
  Enterprise License(同一法人内共有可)¥1,029,600 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、卵巣がん治療薬のグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(PARP、PD-L1、血管新生阻害剤)、用途別市場規模(病院、研究)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。
・市場概要
・卵巣がん治療薬の市場動向
・企業の競争状況、市場シェア
・卵巣がん治療薬の種類別市場規模(PARP、PD-L1、血管新生阻害剤)
・卵巣がん治療薬の用途別市場規模(病院、研究)
・卵巣がん治療薬の北米市場規模2016-2027(アメリカ、カナダ)
・卵巣がん治療薬のヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等)
・卵巣がん治療薬のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・卵巣がん治療薬の中南米市場規模2016-2027(メキシコ、ブラジル)
・卵巣がん治療薬の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Bristol Myers Squibb Company、Eli Lilly and Company、GlaxoSmithKline Plc、Janssen Pharmaceuticals、Genentech Inc.、Astra Zeneca、Boehringer Ingelheim GmbH、Hoffmann La Roche Ltd.)
・結論

Ovarian cancer, and its rising incidence rate, is a growing concern worldwide. Market players that are currently engaged in the development of drugs and therapies for ovarian cancer stand to benefit by observing the latest trends and pipeline competitor products.

Market Analysis and Insights: Global Ovarian Cancer Therapeutics Market
The global Ovarian Cancer Therapeutics market size is projected to reach US$ 2557.7 million by 2026, from US$ 1764.3 million in 2019, at a CAGR of 5.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ovarian Cancer Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ovarian Cancer Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Ovarian Cancer Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Ovarian Cancer Therapeutics market.

Global Ovarian Cancer Therapeutics Scope and Market Size
Ovarian Cancer Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ovarian Cancer Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
PARP
PD-L1
Angiogenesis Inhibitors

Segment by Application
Hosptial
Research

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bristol Myers Squibb Company
Eli Lilly and Company
GlaxoSmithKline Plc
Janssen Pharmaceuticals
Genentech Inc.
Astra Zeneca
Boehringer Ingelheim GmbH
Hoffmann La Roche Ltd.

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ovarian Cancer Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 PARP
1.2.3 PD-L1
1.2.4 Angiogenesis Inhibitors
1.3 Market by Application
1.3.1 Global Ovarian Cancer Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hosptial
1.3.3 Research
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Ovarian Cancer Therapeutics Market Perspective (2016-2027)
2.2 Ovarian Cancer Therapeutics Growth Trends by Regions
2.2.1 Ovarian Cancer Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Ovarian Cancer Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Ovarian Cancer Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Ovarian Cancer Therapeutics Industry Dynamic
2.3.1 Ovarian Cancer Therapeutics Market Trends
2.3.2 Ovarian Cancer Therapeutics Market Drivers
2.3.3 Ovarian Cancer Therapeutics Market Challenges
2.3.4 Ovarian Cancer Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Ovarian Cancer Therapeutics Players by Revenue
3.1.1 Global Top Ovarian Cancer Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Ovarian Cancer Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Ovarian Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Ovarian Cancer Therapeutics Revenue
3.4 Global Ovarian Cancer Therapeutics Market Concentration Ratio
3.4.1 Global Ovarian Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ovarian Cancer Therapeutics Revenue in 2020
3.5 Ovarian Cancer Therapeutics Key Players Head office and Area Served
3.6 Key Players Ovarian Cancer Therapeutics Product Solution and Service
3.7 Date of Enter into Ovarian Cancer Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Ovarian Cancer Therapeutics Breakdown Data by Type
4.1 Global Ovarian Cancer Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Ovarian Cancer Therapeutics Forecasted Market Size by Type (2022-2027)

5 Ovarian Cancer Therapeutics Breakdown Data by Application
5.1 Global Ovarian Cancer Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Ovarian Cancer Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Ovarian Cancer Therapeutics Market Size (2016-2027)
6.2 North America Ovarian Cancer Therapeutics Market Size by Type
6.2.1 North America Ovarian Cancer Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Ovarian Cancer Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Ovarian Cancer Therapeutics Market Size by Type (2016-2027)
6.3 North America Ovarian Cancer Therapeutics Market Size by Application
6.3.1 North America Ovarian Cancer Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Ovarian Cancer Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Ovarian Cancer Therapeutics Market Size by Application (2016-2027)
6.4 North America Ovarian Cancer Therapeutics Market Size by Country
6.4.1 North America Ovarian Cancer Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Ovarian Cancer Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Ovarian Cancer Therapeutics Market Size (2016-2027)
7.2 Europe Ovarian Cancer Therapeutics Market Size by Type
7.2.1 Europe Ovarian Cancer Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Ovarian Cancer Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Ovarian Cancer Therapeutics Market Size by Type (2016-2027)
7.3 Europe Ovarian Cancer Therapeutics Market Size by Application
7.3.1 Europe Ovarian Cancer Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Ovarian Cancer Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Ovarian Cancer Therapeutics Market Size by Application (2016-2027)
7.4 Europe Ovarian Cancer Therapeutics Market Size by Country
7.4.1 Europe Ovarian Cancer Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Ovarian Cancer Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Ovarian Cancer Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Ovarian Cancer Therapeutics Market Size by Type
8.2.1 Asia-Pacific Ovarian Cancer Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Ovarian Cancer Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Ovarian Cancer Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Ovarian Cancer Therapeutics Market Size by Application
8.3.1 Asia-Pacific Ovarian Cancer Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Ovarian Cancer Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Ovarian Cancer Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Ovarian Cancer Therapeutics Market Size by Region
8.4.1 Asia-Pacific Ovarian Cancer Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Ovarian Cancer Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Ovarian Cancer Therapeutics Market Size (2016-2027)
9.2 Latin America Ovarian Cancer Therapeutics Market Size by Type
9.2.1 Latin America Ovarian Cancer Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Ovarian Cancer Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Ovarian Cancer Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Ovarian Cancer Therapeutics Market Size by Application
9.3.1 Latin America Ovarian Cancer Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Ovarian Cancer Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Ovarian Cancer Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Ovarian Cancer Therapeutics Market Size by Country
9.4.1 Latin America Ovarian Cancer Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Ovarian Cancer Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Ovarian Cancer Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Ovarian Cancer Therapeutics Market Size by Type
10.2.1 Middle East & Africa Ovarian Cancer Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Ovarian Cancer Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Ovarian Cancer Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Ovarian Cancer Therapeutics Market Size by Application
10.3.1 Middle East & Africa Ovarian Cancer Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Ovarian Cancer Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Ovarian Cancer Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Ovarian Cancer Therapeutics Market Size by Country
10.4.1 Middle East & Africa Ovarian Cancer Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Ovarian Cancer Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bristol Myers Squibb Company
11.1.1 Bristol Myers Squibb Company Company Details
11.1.2 Bristol Myers Squibb Company Business Overview
11.1.3 Bristol Myers Squibb Company Ovarian Cancer Therapeutics Introduction
11.1.4 Bristol Myers Squibb Company Revenue in Ovarian Cancer Therapeutics Business (2016-2021)
11.1.5 Bristol Myers Squibb Company Recent Development
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Company Details
11.2.2 Eli Lilly and Company Business Overview
11.2.3 Eli Lilly and Company Ovarian Cancer Therapeutics Introduction
11.2.4 Eli Lilly and Company Revenue in Ovarian Cancer Therapeutics Business (2016-2021)
11.2.5 Eli Lilly and Company Recent Development
11.3 GlaxoSmithKline Plc
11.3.1 GlaxoSmithKline Plc Company Details
11.3.2 GlaxoSmithKline Plc Business Overview
11.3.3 GlaxoSmithKline Plc Ovarian Cancer Therapeutics Introduction
11.3.4 GlaxoSmithKline Plc Revenue in Ovarian Cancer Therapeutics Business (2016-2021)
11.3.5 GlaxoSmithKline Plc Recent Development
11.4 Janssen Pharmaceuticals
11.4.1 Janssen Pharmaceuticals Company Details
11.4.2 Janssen Pharmaceuticals Business Overview
11.4.3 Janssen Pharmaceuticals Ovarian Cancer Therapeutics Introduction
11.4.4 Janssen Pharmaceuticals Revenue in Ovarian Cancer Therapeutics Business (2016-2021)
11.4.5 Janssen Pharmaceuticals Recent Development
11.5 Genentech Inc.
11.5.1 Genentech Inc. Company Details
11.5.2 Genentech Inc. Business Overview
11.5.3 Genentech Inc. Ovarian Cancer Therapeutics Introduction
11.5.4 Genentech Inc. Revenue in Ovarian Cancer Therapeutics Business (2016-2021)
11.5.5 Genentech Inc. Recent Development
11.6 Astra Zeneca
11.6.1 Astra Zeneca Company Details
11.6.2 Astra Zeneca Business Overview
11.6.3 Astra Zeneca Ovarian Cancer Therapeutics Introduction
11.6.4 Astra Zeneca Revenue in Ovarian Cancer Therapeutics Business (2016-2021)
11.6.5 Astra Zeneca Recent Development
11.7 Boehringer Ingelheim GmbH
11.7.1 Boehringer Ingelheim GmbH Company Details
11.7.2 Boehringer Ingelheim GmbH Business Overview
11.7.3 Boehringer Ingelheim GmbH Ovarian Cancer Therapeutics Introduction
11.7.4 Boehringer Ingelheim GmbH Revenue in Ovarian Cancer Therapeutics Business (2016-2021)
11.7.5 Boehringer Ingelheim GmbH Recent Development
11.8 Hoffmann La Roche Ltd.
11.8.1 Hoffmann La Roche Ltd. Company Details
11.8.2 Hoffmann La Roche Ltd. Business Overview
11.8.3 Hoffmann La Roche Ltd. Ovarian Cancer Therapeutics Introduction
11.8.4 Hoffmann La Roche Ltd. Revenue in Ovarian Cancer Therapeutics Business (2016-2021)
11.8.5 Hoffmann La Roche Ltd. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Ovarian Cancer Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of PARP
Table 3. Key Players of PD-L1
Table 4. Key Players of Angiogenesis Inhibitors
Table 5. Global Ovarian Cancer Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Ovarian Cancer Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Ovarian Cancer Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Ovarian Cancer Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Ovarian Cancer Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Ovarian Cancer Therapeutics Market Share by Regions (2022-2027)
Table 11. Ovarian Cancer Therapeutics Market Trends
Table 12. Ovarian Cancer Therapeutics Market Drivers
Table 13. Ovarian Cancer Therapeutics Market Challenges
Table 14. Ovarian Cancer Therapeutics Market Restraints
Table 15. Global Ovarian Cancer Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Ovarian Cancer Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Ovarian Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ovarian Cancer Therapeutics as of 2020)
Table 18. Ranking of Global Top Ovarian Cancer Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Ovarian Cancer Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Ovarian Cancer Therapeutics Product Solution and Service
Table 22. Date of Enter into Ovarian Cancer Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Ovarian Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Ovarian Cancer Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Ovarian Cancer Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Ovarian Cancer Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Ovarian Cancer Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Ovarian Cancer Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Ovarian Cancer Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Ovarian Cancer Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Ovarian Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Ovarian Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Ovarian Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Ovarian Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Ovarian Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Ovarian Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Ovarian Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Ovarian Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Ovarian Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Ovarian Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Ovarian Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Ovarian Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Ovarian Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Ovarian Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Ovarian Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Ovarian Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Ovarian Cancer Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Ovarian Cancer Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Ovarian Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Ovarian Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Ovarian Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Ovarian Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Ovarian Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Ovarian Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Ovarian Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Ovarian Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Ovarian Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Ovarian Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Ovarian Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Ovarian Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Bristol Myers Squibb Company Company Details
Table 63. Bristol Myers Squibb Company Business Overview
Table 64. Bristol Myers Squibb Company Ovarian Cancer Therapeutics Product
Table 65. Bristol Myers Squibb Company Revenue in Ovarian Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 66. Bristol Myers Squibb Company Recent Development
Table 67. Eli Lilly and Company Company Details
Table 68. Eli Lilly and Company Business Overview
Table 69. Eli Lilly and Company Ovarian Cancer Therapeutics Product
Table 70. Eli Lilly and Company Revenue in Ovarian Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Eli Lilly and Company Recent Development
Table 72. GlaxoSmithKline Plc Company Details
Table 73. GlaxoSmithKline Plc Business Overview
Table 74. GlaxoSmithKline Plc Ovarian Cancer Therapeutics Product
Table 75. GlaxoSmithKline Plc Revenue in Ovarian Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 76. GlaxoSmithKline Plc Recent Development
Table 77. Janssen Pharmaceuticals Company Details
Table 78. Janssen Pharmaceuticals Business Overview
Table 79. Janssen Pharmaceuticals Ovarian Cancer Therapeutics Product
Table 80. Janssen Pharmaceuticals Revenue in Ovarian Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Janssen Pharmaceuticals Recent Development
Table 82. Genentech Inc. Company Details
Table 83. Genentech Inc. Business Overview
Table 84. Genentech Inc. Ovarian Cancer Therapeutics Product
Table 85. Genentech Inc. Revenue in Ovarian Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Genentech Inc. Recent Development
Table 87. Astra Zeneca Company Details
Table 88. Astra Zeneca Business Overview
Table 89. Astra Zeneca Ovarian Cancer Therapeutics Product
Table 90. Astra Zeneca Revenue in Ovarian Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Astra Zeneca Recent Development
Table 92. Boehringer Ingelheim GmbH Company Details
Table 93. Boehringer Ingelheim GmbH Business Overview
Table 94. Boehringer Ingelheim GmbH Ovarian Cancer Therapeutics Product
Table 95. Boehringer Ingelheim GmbH Revenue in Ovarian Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Boehringer Ingelheim GmbH Recent Development
Table 97. Hoffmann La Roche Ltd. Company Details
Table 98. Hoffmann La Roche Ltd. Business Overview
Table 99. Hoffmann La Roche Ltd. Revenue in Ovarian Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Hoffmann La Roche Ltd. Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ovarian Cancer Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. PARP Features
Figure 3. PD-L1 Features
Figure 4. Angiogenesis Inhibitors Features
Figure 5. Global Ovarian Cancer Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Hosptial Case Studies
Figure 7. Research Case Studies
Figure 8. Ovarian Cancer Therapeutics Report Years Considered
Figure 9. Global Ovarian Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Ovarian Cancer Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Ovarian Cancer Therapeutics Market Share by Regions: 2020 VS 2027
Figure 12. Global Ovarian Cancer Therapeutics Market Share by Regions (2022-2027)
Figure 13. Global Ovarian Cancer Therapeutics Market Share by Players in 2020
Figure 14. Global Top Ovarian Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ovarian Cancer Therapeutics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Ovarian Cancer Therapeutics Revenue in 2020
Figure 16. Global Ovarian Cancer Therapeutics Revenue Market Share by Type (2016-2021)
Figure 17. Global Ovarian Cancer Therapeutics Revenue Market Share by Type (2022-2027)
Figure 18. North America Ovarian Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Ovarian Cancer Therapeutics Market Share by Type (2016-2027)
Figure 20. North America Ovarian Cancer Therapeutics Market Share by Application (2016-2027)
Figure 21. North America Ovarian Cancer Therapeutics Market Share by Country (2016-2027)
Figure 22. United States Ovarian Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Ovarian Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Ovarian Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Ovarian Cancer Therapeutics Market Share by Type (2016-2027)
Figure 26. Europe Ovarian Cancer Therapeutics Market Share by Application (2016-2027)
Figure 27. Europe Ovarian Cancer Therapeutics Market Share by Country (2016-2027)
Figure 28. Germany Ovarian Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Ovarian Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Ovarian Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Ovarian Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Ovarian Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Ovarian Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Ovarian Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Ovarian Cancer Therapeutics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Ovarian Cancer Therapeutics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Ovarian Cancer Therapeutics Market Share by Region (2016-2027)
Figure 38. China Ovarian Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Ovarian Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Ovarian Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Ovarian Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Ovarian Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Ovarian Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Ovarian Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Ovarian Cancer Therapeutics Market Share by Type (2016-2027)
Figure 46. Latin America Ovarian Cancer Therapeutics Market Share by Application (2016-2027)
Figure 47. Latin America Ovarian Cancer Therapeutics Market Share by Country (2016-2027)
Figure 48. Mexico Ovarian Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Ovarian Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Ovarian Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Ovarian Cancer Therapeutics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Ovarian Cancer Therapeutics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Ovarian Cancer Therapeutics Market Share by Country (2016-2027)
Figure 54. Turkey Ovarian Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Ovarian Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Ovarian Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Bristol Myers Squibb Company Revenue Growth Rate in Ovarian Cancer Therapeutics Business (2016-2021)
Figure 58. Eli Lilly and Company Revenue Growth Rate in Ovarian Cancer Therapeutics Business (2016-2021)
Figure 59. GlaxoSmithKline Plc Revenue Growth Rate in Ovarian Cancer Therapeutics Business (2016-2021)
Figure 60. Janssen Pharmaceuticals Revenue Growth Rate in Ovarian Cancer Therapeutics Business (2016-2021)
Figure 61. Genentech Inc. Revenue Growth Rate in Ovarian Cancer Therapeutics Business (2016-2021)
Figure 62. Astra Zeneca Revenue Growth Rate in Ovarian Cancer Therapeutics Business (2016-2021)
Figure 63. Boehringer Ingelheim GmbH Revenue Growth Rate in Ovarian Cancer Therapeutics Business (2016-2021)
Figure 64. Hoffmann La Roche Ltd. Revenue Growth Rate in Ovarian Cancer Therapeutics Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed



• 英文レポート名:Global Ovarian Cancer Therapeutics Market Size, Status and Forecast 2021-2027
• 日本語訳:卵巣がん治療薬の世界市場2021-2027
• レポートコード:QYR2104Z4379お問い合わせ(見積依頼・ご注文・質問)